Items tagged with Treatment
Unitaid to partner with communities and civil society to drive access to new drug-resistant TB treatment regimens with new call for proposals (post)
Geneva, 20 September 2023 – As the United Nations General Assembly convenes world leaders at the High-Level Meeting on Tuberculosis (TB) this week, discussions will focus on the urgent need for access and innovation to put an end to a disease that we have known how to cure for decades. Despite this, TB continues to kill more people each year than any other infectious disease.
Patients’ rights groups accuse Union health ministry of denying shortages of key medicines for drug-resistant TB (post)
Patients’ rights groups have accused the Union health ministry of denying shortages of key medicines for drug-resistant tuberculosis (TB) even though they say the ministry’s own figures of drug inventories indicate why patients are facing shortages.
TB patients across India struggle with acute drug shortages, government denies but WHO worried (post)
New Delhi, 01/Oct/2023: In an unusual repetition of sorts, the Union health ministry issued a press release on Sunday, October 1, denying any shortages of essential medicines for drug-resistant TB patients. It was only on September 26 that the ministry issued an almost similar statement.
Finding a balance in antibiotic medicine: can we kill ‘bad’ bacteria while preserving the ‘good’? (post)
A study led by scientists at University of St Andrews has found that antibiotics used to treat tuberculosis kill other potentially useful bacteria.
Johnson & Johnson lifts patent on MDR-TB drug but it may be years before South Africa benefits (post)
Pharmaceutical giant Johnson & Johnson (J&J) recently announced that it would lift patents on the life-saving drug bedaquiline.
New TB infections likely to increase, as Kenya runs out of supply of drugs (post)
Kenya is likely to lose gains made in the fight against TB, a leading infectious disease, following an acute shortage of drugs.
Life-saving TB drug is now cheaper in South Africa, but not as cheap as it can be (post)
The South African government and pharmaceutical company Johnson & Johnson (J&J) have agreed to a lower price for bedaquiline, a medicine used to treat drug-resistant tuberculosis (DR-TB) in South Africa.
A new dawn in the fight against TB: UNITE4TB announces start of clinical trials (post)
The UNITE4TB Consortium is proud to announce the start of its phase 2B/C clinical trial program. The announcement is a major milestone for the project and the TB community as a whole, helping to advance TB science and enhance the efficiency with which new treatments are delivered.
Janssen submits Phase 3 study data to the European Medicines Agency and U.S. Food and Drug Administration for SIRTURO® (bedaquiline) (post)
STREAM Stage 2 study data submitted as part of Type II Variation to European Medicines Agency and supplemental New Drug Application to U.S. FDA aim to support the full and traditional approval in the European Union and U.S., respectively.
TB Alliance applauds Macleods’ launch of a key component of WHO-recommended drug-resistant TB treatment regimen (post)
Macleods becomes second pharmaceutical manufacturer to bring pretomanid supply to market and first since the World Health Organization issued updated DR-TB treatment guidelines.
Page 72 of 108 · Total posts: 0
←First 71 72 73 Last→